case_images: PMC8214346_01
case_images: Serial (A) weight and heart rate; (B) thyroid function and TRAb titres and (C) daily dose of oral carbimazole (CMZ) therapy, in a patient with T3-predominant Graves' hyperthyroidism. TSH was suppressed from 11/9/17 to 6/11/17 (8 weeks with low fT4 and normal fT3), further suppressed on 13/12/17 (T3 toxicosis) and went from suppressed to normal from 7/2/18 to 24/3/18 (6 weeks with low fT4 and normal T3).
case_images: JAFES-36-1-085-g001.jpg
case_images: PMC8214346_01_JAFES-36-1-085-g001.jpg
case_images: f0001
case_images: The course of her weight, heart rate, thyroid function test (TFT) and CMZ daily dosage are depicted in Figures 1A to C respectively. Over a span of 7 months, her serum TSH showed inappropriate suppressed or inappropriate normal levels when fT4 was low and T3 normal, as well as transient appropriate suppression due to T3 toxicosis (Figure 1B).
case_images: Thyroid function profile before and within 24-hours after total thyroidectomy with intravenous levothyroxine 500 mcg loading.
case_images: JAFES-36-1-085-g002.jpg
case_images: PMC8214346_01_JAFES-36-1-085-g002.jpg
case_images: f0002
case_images: Her perioperative thyroid function tests in the first 24-hours post total-thyroidectomy are depicted in Figure 2.